10-K Decoder · All companies

Immuneering Corporation

IMRX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$0K$0K
Operating income−$59.4M−$64.1M+7.3%
Net income−$56.0M−$61.0M+8.2%

Questions

What was Immuneering's revenue in FY2025?
$0K in FY2025 (Fiscal year ended Dec 31, 2025), no comparable figure vs $0K a year earlier, per its 10-K filed Mar 2026.
Was Immuneering profitable in FY2025?
No: net income was −$56.0M and operating income −$59.4M in FY2025.